NCT00128310View on ClinicalTrials.gov

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

January 18, 2001

Primary Completion Date

August 15, 2006

Study Completion Date

January 24, 2008

Conditions
Breast CancerNeoplasm Metastasis
Interventions
DRUG

Vinorelbine

DRUG

Gemcitabine

Trial Locations (2)

28700

Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes

Unknown

Grupo Andino de Investigación en Oncología (GAICO), Valencia

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER

NCT00128310 - Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter